TIAA-CREF Investment Management, LLC 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-11 12:24 pm Sale |
2024-02-29 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 4,955,411 2.170% |
-107,134 (-2.12%) |
Filing |
| 2024-02-14 11:37 am Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 5,062,545 2.240% |
-420,824 (-7.67%) |
Filing |
| 2023-02-14 08:47 am Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 5,483,369 2.480% |
5,483,369 (New Position) |
Filing |